Concepedia
Statistics
Publications
53
Citations
3.1K
Authors
10
Location
Laval, Canada
Vertex Pharmaceuticals (Canada) is a company institution in Laval, Canada known for medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryMedicinal ChemistryBiochemistryDrug DevelopmentNatural SciencesImmunologyVirologyChemical Biology
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text
Influenza Pb2, Medicinal Chemistry, Medicine +13
Methicillin‐Resistant <i>Staphylococcus aureus</i>: A Public Health Issue with Economic Consequences
Mireille Goetghebeur, Pierre‐Alexandre Landry, Donald Han et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 2006 · 113 citations · Full text
Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia
Hélène David, Benoît Haelewyn, Christophe Rouillon et al. · The FASEB Journal · 2007 · 104 citations
Anesthetic Mechanism, Pharmacotherapy, Anesthetic Gas Xenon +21
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations
Immunology, Immunologic Mechanism, Janus Tyrosine Kinases +16
Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
Erik S. Linklater, Elizabeth A. Tovar, Curt J. Essenburg et al. · Oncotarget · 2016 · 77 citations · Full text
Breast Oncology, Kinase Inhibitors, Cancer Biology +16
Rows per page
1–5 of 53
Vertex Pharmaceuticals (Canada), Canada
29 publications · 725 citations
12
h-index
18 publications · 544 citations
11 publications · 308 citations
8
15 publications · 154 citations
11 publications · 187 citations
7
1–5 of 10